Final Results

Primary Health Properties PLC 17 September 2004 Primary Health Properties PLC 17 September 2004 Embargoed for release at 7am on 17 September 2004 PRIMARY HEALTH PROPERTIES PLC ('PHP') Modern accommodation for the Provision of Primary Health Care Services Preliminary Results for the year ended 30 June 2004 Group Financial Highlights *Pre tax profits increased by 13% to £2,472,000 (2003: £2,179,000) *Basic earnings per share increased by 18% to 13.9p (2003: 11.8p) *Diluted earnings per share increased by 19% to 12.8p (2003: 10.8p) *Dividend increased 10% to 11.00p (2003: 10.0p) *Basic NAV per share increased 21% to 274.7p (2003: 226.8p) *Fully diluted NAV per share increased 21% to 243.7p (2003: 200.6p) *Portfolio (including finance leases) increased to £131.1m (2003: £96.3m) *Total return per share increased to 59.0p (2003: 55.5p) Harry Hyman, Managing Director, commented: "All of our key performance indicators have increased during the period, and I am delighted to report a 21% increase in our NAV per share, along with a 10% increase on our total dividend. Primary Health Properties operates in a fast growing property sector. Demand continues across the country for new medical centres and combined with the increased resources being made available by the Government to the NHS we will see the modernisation of the Primary Care Estate. We are optimistic that this will result in an increased flow of deals for Primary Health Properties." Enquiries: Bell Pottinger Financial David Rydell/Zoe Sanders Tel: 020 7861 3232 Primary Health Properties PLC Harry Hyman Managing Director Tel: 01483 306912 Mobile: 07973 344768 Chairman's Statement This was another good year for Primary Health Properties. The Group produced a further year of profit growth with Group profit before taxation for the year ended 30 June 2004 totalling £2,472,000, (2003: £2,179,000), an increase of 13.4%. Diluted earnings per share increased by 19% to 12.8p (2003: 10.8p). This higher increase resulted primarily from the fact that no UK corporation tax was charged to profits during the year (2003: £226,000). In addition the Group posted its highest ever fully diluted net asset value of 243.7p per share, a rise of 21.5%. The diluted total return for the year was 54.0p (2003: 41.6p). The Board has recommended a final dividend of 5.5p per Ordinary share that with the interim dividend makes a total of 11.0p per share for the year, an increase of 10% over the total dividend of 10.0p per share paid in respect of the previous year. The Board has the authority to offer Ordinary shares instead of cash in respect of dividends. A circular offering Shareholders on the register on 24 September 2004 the opportunity to receive new Ordinary shares instead of the cash dividend in respect of the final dividend together with a form of election and/or Notice of Entitlement will be posted to Shareholders with the Annual Report. The latest date for receipt of the Forms of Election is 28 October 2004. The year end valuation carried out on behalf of the Board by Lambert Smith Hampton has resulted in a revaluation surplus of some £10.1m for the year. Of this £4.0m was accounted for at the interim stage. The undiluted net asset value per share has risen from 226.8.p per share to 274.7p and the diluted net asset value from 200.6p to 243.7p, reflecting both rental increases and current yields in the market. In addition, the calculation of the net asset value was affected by the exercise of options resulting in the issue of 1,386,667 Ordinary shares at £1 each and the issue of 43,489 Ordinary shares pursuant to the scrip dividend scheme. On 19 August 2004 the Royal Bank of Scotland converted its £4.0m Convertible Unsecured Loan Stock 2016. This has resulted in the issue of a further 3,478,260 Ordinary shares of 50p each. The number of Ordinary shares in issue is now 21,625,393. Rent reviews during the year have again performed well and at the year end our rent roll had increased from £6.9m to £8.4m, an increase of 22%. During January 2004, we agreed a further increase of £20m in our banking facilities, which total £95m. As announced in the interim report, the Board has decided to recommend to shareholders at the Annual General Meeting an increase in the Group's permitted gearing level to 75% of Gross Assets. This would enable the Group to expand its portfolio to £215m based on existing equity and quasi equity resources. Purchase of properties amounted to £24.9m during the year and our commitments at the year end totalled £18.2m. Our portfolio, including commitments, was £149.3m at 30 June 2004, an increase from £109.6m at the previous year end. Expansion during the year has in part been financed by the share issues noted above and further drawings on our committed medium term finance facilities. We have continued to monitor our exposure to interest rates and have entered into a new £10m swap arrangement for six years from 2007 to 2013 and a new £10m swap arrangement for ten years from 2004 to 2014. For the year to 30 June 2005 we have covered approximately 64.3% of our exposure to interest rates at an average rate before margin of 5.24% falling to approximately 31.5% in five years time with an average rate before margin of 5.55% The share save scheme has 33 members holding 37,937 shares. The portfolio at the date of this report has 59 properties with a further 9 contracted for delivery during the next 12 months. The portfolio has performed well in both capital and income terms and we believe that although there is increased competition in the market place, the prospects for investment in the sector with its long lease lengths and good quality covenants make the portfolio highly attractive. G A Elliot Chairman 16 September 2004 Managing Director's Report The table below sets out the development of our portfolio during the year under review. We took delivery of ten new developments (2003: six new developments) and entered into a further nine development commitments (2003: eight development commitments). At the year end the portfolio, when commitments are included, reached £149.3m (2003 £109.6m) as set out below. Portfolio Movements 30 June 2004 30 June 2003 £m £m Investment properties 122.6 92.3 Properties in course of development* 6.0 1.4 Finance leases 2.5 2.6 Total owned and leased 131.1 96.3 Deposits paid - 0.2 Committed 18.2 13.1 Total owned, leased and committed 149.3 109.6 *Properties in the course of development include development loans. Portfolio Purchases During the Year The Group completed the purchases of a number of properties during the year, details of which are set out below: Property Acquisition Cost Occupational Tenants £m Skegness, Lincolnshire 2.0 Doctors Practice, PCT and Pharmacy Aspley , Nottingham 1.1 Doctors Practice Boston, Lincolnshire 2.2 Doctors Practice, PCT and Pharmacy Amwell Street, London 4.4 Doctors Practice Lenton, Nottingham 1.8 Doctors Practice and Pharmacy Oldbury, West Midlands 2.8 Doctors Practice and Pharmacy Pengam Green, Cardiff 1.4 Doctors Practice Gatley, Cheshire 1.7 Doctors Practice Winchcombe, Gloucestershire 1.0 Doctors Practice Gosport, Hampshire 1.6 Doctors Practice and Pharmacy TOTAL 20.0 Revaluation As reported in the Chairman's Statement, the portfolio valuations have resulted in an uplift of some £10m which has been incorporated into the balance sheet, giving a closing property investment valuation (including finance leases) of £131.1m. This increase amounted to 55.1p per share on an undiluted basis and 43.3p per share on a fully diluted basis. Portfolio Rental Levels The average rent across the whole portfolio is around £155 per square metre (£14.40 per square foot) (2003: £150 per square metre, £14 per square foot). The average rent on accommodation let to the NHS (either directly or through the Doctors Rent and Rates Scheme) is approximately £149 per square metre (£13.85 per square foot) (2003: £148 per square metre, £13.75 per square foot) and the average pharmacy rent is around £190 per square metre (£17.70 per square foot) (2003: £200 per square metre, £18.50 per square foot). Rent Reviews The Group completed a number of rent reviews during the year and there are a number of reviews outstanding that we expect to see resolved during the coming year. The results of the reviews completed during the year added some £74,000 to our rent roll. There are further reviews due from the past year which amount to some £1.64m of rent passing. The table below shows the timing of reviews across our portfolio. The pace of reviews is now picking up as more evidence is presented through the market and more premises go through the review process. The weighted average length of time to the next review is 1.66 years across the portfolio. Future Accounting Standards For accounting periods starting after 1 January 2005, all listed companies in the UK which present consolidated financial statements, have to comply with International Accounting Standards. These standards are different from UK GAAP in a number of areas, including IAS40 with regard to the definition of Investment properties and IAS12 in connection with Deferred Tax. The Directors are currently assessing the impact that this will have on the Group. The extent to which the change to IAS will have on UK Company Law is currently the subject of consultation by the DTI. The Directors will address these proposals in due course. Finance and Interest Rate Hedging Bank borrowings increased from £50.2m to £72.2m during the year. Including the convertible loan stock of £4.0m year end borrowings totalled £76.2m of which £49.0m has been hedged as follows: Convertible 2016 fixed rate of 7.75% £4.0m Swaps at average rate of 5.303% £45.0m Total fixed rate and hedged debt £49.0m The average weighted cost of finance for the fixed element of the debt is 5.50% (2003: 5.60%) (excluding the lender's margin). During the period a number of swaps have been entered into extending the maturity of the Group's cover under hedging arrangements as shown below. Fixed Rate Funding Year Swaps (£m) Convertible Loan Total (£m) Stock (£m) 2004/2005 45.0 4.0 49.0 2005/2006 45.0 4.0 49.0 2006/2007 40.0 4.0 44.0 2007/2008 30.0 4.0 34.0 2008/2009 20.0 4.0 24.0 2009/2010 20.0 4.0 24.0 The table above shows the level of fixed rate financing for each of the next 6 financial years from swaps and the convertible loan stock. The Group has facilities of £95m and is discussing the possibility of adding further bank lines. £10m is on a 364 day facility basis while the balance of £85m is a 7 year bullet facility repayable in 2008. The Company has negotiated an option to extend its ability to convert all of its term facilities of £95m into longer term finance that would mature in 2022, whilst retaining the flexibility to refinance if considered attractive. Convertible Loan Stock March 2016 On 19 August 2004, the Royal Bank of Scotland converted its £4.0m Convertible Unsecured Loan Stock 2016. This has resulted in the issue of a further 3,478,260 Ordinary shares of 50p each. Portfolio characteristics Users The table below shows the percentage of our portfolio by rent roll derived from each of our major tenant classes, GPs, Primary Care Trusts ('PCTs'), Health Authorities, pharmacy operators and others. Some 99% (2003: 99%) of our rent roll comes directly or indirectly from the NHS and pharmacy operators. Covenant Analysis by Annual Rent GP's 74% Health Authorities 4% PCTs 14% Pharmacy 7% Other 1% TOTAL 100% Length of Leases Two tables below show the length of lease by lease expiry and percentage of today's passing rent. A third table below, sets out the security of income by term certain. The first table indicates that some 90% (2003: 91%) of the lease income has more than 15 years unexpired, whilst the security of the income table shows the contracted cash flow as a percentage of the year end rent roll, ignoring any increases and any lease renewals during the subsequent periods. This shows that by year 20 the Group would still be receiving 63% of its current income while at year 18 the figure is 83%. Analysis of Annual Rent by Term Unexpired Less than 5 years 1% 6 - 15 years 9% 15 - 20 years 37% More than 20 years 53% TOTAL 100% Security of Income by Lease Expiry Year % of Passing Rent 1 100% 5 99% 10 94% 15 92% 20 63% Security of Income by Term Certain Year % of Passing Rent 1 100% 5 99% 10 94% 15 90% 20 63% Geographical Spread The table below shows the percentage of the portfolio by rent roll derived from each of the NHS regions. Anglia and Oxford 14% North Thames 18% North West 12% Northern and Yorkshire 12% South Thames 4% South and West 9% Trent 9% West Midlands 15% Scotland 3% Wales 4% TOTAL 100% Forthcoming Reviews The table below shows the annual amount of rent falling due for review in each of the next 3 years. Year Rent (£m) 2004/2005 2.581 2005/2006 2.875 2006/2007 2.515 The Primary Care Market Over the last year we have seen the Government's much heralded NHS LIFT (Local Improvement Finance Trust) programme set up across many deprived areas in England. Although 42 schemes are currently being developed across the country, only 5 LIFT schemes have established the LIFTCo - the joint venture partnership company between the public and private sectors - and only 28 have completed the bidding process. We continue to watch the developments with interest. Outside of the NHS LIFT remit, we are encouraged to see that Third Party Developer schemes are occurring within LIFT areas and we completed the purchase of a new medical centre in Oldbury during the past year. This proves that the market is still strong, working alongside LIFT, and we look forward to purchasing future projects in these areas. Throughout the rest of the country, demand for new medical centres continues apace. There is more cohesion within PCTs to see the primary care framework evolve and to see the improvement of patient services, whether delivered direct from PCT community services or from General Practitioners. The investment market for new primary care facilities has expanded over the last year with new investors coming into the market. Whilst this will help to develop the primary care premises market, we must continue to invest prudently and take full advantage of the position we hold in the marketplace. We have continued to add value to properties in the portfolio by negotiating new lease terms and refurbishing premises. For example, we successfully negotiated a lease extension on Lever Chambers in Bolton, to extend the term certain to 20 years from 7 years, adding significant value to the investment. Future Prospects We are optimistic that the increased resources made available by the Government to the NHS will assist in the modernisation of the Primary Care Estate and that this will translate into an increased flow of deals for PHP. In the mean time our existing portfolio continues to perform well and we are working hard to add value from rent reviews and lease re-gearing. Harry Hyman Managing Director 16 September 2004 CONSOLIDATED PROFIT AND LOSS ACCOUNT for the year ended 30 June 2004 30 June 2004 30 June 2003 £'000 £'000 Turnover 7,661 6,711 Administrative expenses (1,738) (1,399) Operating profit 5,923 5,312 Share of operating profit/(loss) in joint venture 4 (178) 5,927 5,134 Interest receivable 183 55 Interest payable (3,638) (3,010) Profit on ordinary activities before taxation 2,472 2,179 Taxation - (226) Profit on ordinary activities after taxation 2,472 1,953 Interim dividend of 5.50p per share (2003: 5.00p) (997) (835) Final dividend proposed of 5.50p per share (2003: 5.00p) (998) (836) Additional final dividend 2003 * (69) - (2,064) (1,671) Profit retained for the year 408 282 Net profit after tax and dividends for the year retained by: The Company 398 450 Subsidiary undertakings (after declaring dividends of £7,515,000 (2003: 6 10 £6,340,000)) Joint venture 4 (178) 408 282 Earnings per share - basic 13.9p 11.8p - diluted 12.8p 10.8p Dividends per share (net) 11.0p 10.0p Increase in net asset value per share - basic 48.0p 45.5p - fully diluted 43.0p 36.0p Total return per share - basic 59.0p 55.5p - diluted 54.0p 46.0p All activities are continuing. * Additional Final dividend 2003 - as result of the Joint Managers exercise of options to purchase 1,386,667 Ordinary shares on 17 September 2003, they were entitled as shareholders of these new shares on the registrar at 26 September 2003 to receive the final dividend in respect of the year ended 30 June 2003. CONSOLIDATED STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES for the year ended 30 June 2004 30 June 2004 30 June 2003 £'000 £'000 Profit for the financial year excluding share of profit/(loss) in joint 2,468 2,131 venture Share of joint venture's profit/(loss) for the year 4 (178) Profit for the financial year attributable to members of the Parent Company 2,472 1,953 Unrealised surplus on revaluation of properties 10,050 7,497 Total gains and losses relating to the year 12,522 9,450 All activities are continuing. CONSOLIDATED BALANCE SHEET as at 30 June 2004 At 30 June At 30 June 2004 2003 £'000 £'000 Fixed Assets Tangible assets 128,612 93,710 Investment in joint venture: Share of gross assets 4 75 Share of gross liabilities (4) (106) - (31) 128,612 93,679 Current assets Debtors 1,104 658 Net investment in finance leases (due within one year: 2004: £27,000, 2003: 2,549 2,573 £28,000) Cash at bank 709 418 4,362 3,649 Creditors: amounts falling due within one year (6,911) (5,219) Net current liabilities (2,549) (1,570) Total assets less current liabilities 126,063 92,109 Creditors: amounts falling due after more than one year Bank loans (72,210) (50,200) Convertible loan stock 2016 (4,000) (4,000) (76,210) (54,200) 49,853 37,909 Capital and reserves Called up share capital 9,074 8,358 Share premium account 7,459 6,689 Capital reserve 1,618 1,618 Revaluation reserve 30,303 20,253 Profit and loss account 1,399 991 Equity shareholders' funds 49,853 37,909 Net asset value per share - basic 274.72p 226.77p - diluted 243.65p 200.61p CONSOLIDATED CASH FLOW STATEMENT for the year ended 30 June 2004 30 June 2004 30 June 2003 £'000 £'000 Net cash inflow from operating activities 6,167 5,916 Returns on investments and servicing of finance Interest received 16 10 Interest paid (3,157) (2,351) (3,141) (2,341) Taxation UK corporation tax recovered - 3 Capital expenditure and financial investment Payments to acquire tangible fixed assets (21,077) (8,536) Development loans advanced (3,223) - Loan to joint venture (27) (100) (24,327) (8,636) Equity dividends paid (1,804) (1,544) Net cash outflow before financing (23,105) (6,602) Financing Ordinary share issue (net of expenses) 1,386 209 Term bank loan 2008 22,010 10,200 Revolving 364 day facility - (3,750) Net cash inflow from financing 23,396 6,659 Increase in cash 291 57 RECONCILIATION OF NET CASH FLOW TO MOVEMENT IN NET DEBT 30 June 30 June 2004 2003 £'000 £'000 Increase in cash in the period 291 57 Cash inflow from loans (22,010) (6,450) Movement in net debt in the period (21,719) (6,393) At the beginning of the period (53,782) (47,389) At the end of the period (75,501) (53,782) Net debt comprises: Cash at bank and in hand 709 418 Term loan (72,210) (50,200) Convertible Loan Stock 2016 (4,000) (4,000) (75,501) (53,782) NOTES: The above results for the year to 30 June 2004 are audited. 1. Earnings per share The calculation of earnings per share is based on the following: As at 30 June 2004 As at 30 June 2003 Net profit attributable Ordinary Net profit attributable Ordinary to ordinary shareholders shares to ordinary shareholders shares £'000 number £'000 number Basic earnings 2,472 17,824,559 * 1,953 16,612,427 * per share Option - 439,074 - 603,528 conversion** Convertible 310 3,478,260 279 3,478,260 Loan stock conversion*** Diluted 2,782 21,741,893 2,232 20,694,215 earnings per share * Weighted average number of Ordinary shares in issue during the year. ** Excess of the total number of potential shares on option exercise over the number that could be issued at fair value as calculated in accordance with Financial Reporting Standard No. 14: Earnings per share. *** The total number of potential shares on conversion of the convertible loan stock. 2. Notes to the statement of cash flow Reconciliation of operating profit to net cash inflow from operating activities 30 June 30 June 2004 2003 £'000 £'000 Operating profit 5,923 5,312 (Increase)/decrease in operating debtors and prepayments (289) 272 Increase in operating creditors and accruals 533 332 Net cash inflow from operating activities 6,167 5,916 3. The freehold properties are included at valuation as at 30 June 2004. Fixed assets consist of: 30 June 30 June 2004 2003 £'000 £'000 Tangible assets: Investment properties 125,266 93,699 Development Loans 3,346 11 128,612 93,710 Investments: Investment in joint venture Share of gross assets 4 75 Share of gross liabilities (4) (106) - (31) 128,612 93,679 JOINT VENTURE Primary Health Properties plc owns 50% of the issued Ordinary share capital of Primary Health Solutions Limited, a company created for the purpose of developing properties for sale and leaseback and to tender for contracts under the Government's LIFT (Local Improvement Finance Trust) initiative. The remaining 50% of the issued Ordinary share capital is owned by Brackley Investments Limited. 4. At the Annual General Meeting, a resolution to declare a final dividend of 5.5p per share will be put to the members and will be paid on 25 November 2004 to holders registered at close of business on 24 September 2004. 5. Fully diluted net asset value has been calculated as follows: 30 June 30 June 2004 2003 £'000 £'000 (audited) (audited) Net assets: Per Consolidated Balance Sheet 49,853 37,909 Add - Loan Stock conversion 4,000 4,000 - Receipts from the exercise of Options 2,736 1,387 56,589 43,296 No. of shares No. of shares Ordinary shares: Issued share capital 18,147,133 16,716,977 Add - Loan Stock conversion into shares 3,478,260 3,478,260 New shares issued on exercise of options 1,600,000 1,386,667 23,225,393 21,581,904 Calculations assume that the dilution takes place on the respective balance sheet dates. 6. On 19 August 2004, 3,478,260 Ordinary shares of 50 pence each were issued arising on the conversion of £4.0m Convertible Loan Stock 2016. The new Ordinary shares do not rank for the final dividend for the year ended 30 June 2004. 7. The statutory accounts for the year ended 30 June 2004 will be finalised on the basis of the financial information presented by the Directors in this preliminary announcement and will be delivered to Registrar of Companies following the Company's Annual General Meeting. The Annual Report will be sent to shareholders shortly and will also be available on request from the Company Secretary, J O Hambro Capital Management Limited, Ground Floor, on 18 November 2004 at 2.30pm at Ground Floor, Ryder Court, 14 Ryder Street, London, SW1Y 6QB. 8. At the Extraordinary General Meeting held on 21 November 2002, the Directors were granted authority to offer Ordinary shares instead of cash in respect of dividends. A Circular, Form of Election and Notice of Entitlement will be posted to Shareholders on 6 October 2004 offering Shareholders on the Register of Members on 24 September 2004 the opportunity to elect to receive new Ordinary shares instead of cash in respect of the final dividend. The latest date for receipt of the Forms of Election is 28 October 2004. 9. The financial information set out above does not constitute the Company's statutory financial statements for the years ended 30 June 2004 or 2003 (but is derived from and has been prepared on the same basis as those financial statements). Statutory financial statements for 2003 have been delivered to the Registrar of Companies, and those for 2004 will be delivered following the Company's Annual General Meeting. The auditors have reported on those financial statements; their reports were unqualified and did not contain statements under section 237 (2) or (3) of the Companies Act 1985. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings